Best Pharmaceuticals For Children Act Pediatric Trials Network (BPCA PTN)

The Department of Health and Human Services, National Institute of Child Health and Human Development (NICHD) has a continuing requirement for the design and overseeing of the clinical, scientific, and technical aspects of a multi-site network of clinical sites to conduct research in pediatric therapeutic areas.

Solicitation Summary

The Department of Health and Human Services, National Institute of Child Health and Human Development (NICHD) has a continuing requirement for the design and overseeing of the clinical, scientific, and technical aspects of a multi-site network of clinical sites to conduct research in pediatric therapeutic areas.

Solicitation in a Nutshell

Item

Details

Agency The Department of Health and Human Services, National Institute of Child Health and Human Development (NICHD)
Solicitation Number 75N94024R00008
Status Pre-RFP
Solicitation Date 09/2025 (Estimate)
Award Date 06/2026 (Estimate)
Contract Ceiling Value $96,000,000.00
Solicitation Number 75N94024R00008
Competition Type Undetermined
Type of Award IDIQ – Agency Specific
Primary Requirement Research & Development
Duration 8 year(s) base
Contract Type Indefinite Delivery Indefinite Quantity
No. of Expected Awards N/A
NAICS Code(s):
541715

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Size Standard: 1000 Employees except 1500 Employees for Aircraft, Aircraft Engine and Engine Parts, 1250 Employees for Other Aircraft Parts and Auxiliary Equipment and 1300 Employees for Guided Missiles and Space Vehicles, Their Propulsion Units and Propulsion Parts

Place of Performance:
  • United States
    • Contractor Facilities
Opportunity Website: https://sam.gov/opp/845036f285ca4e9ebcce92fc4716191c/view

Background

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) provides direct support for clinical research and clinical research networks that focus on particular diseases or public health issues. One of the goals of NICHD is to conduct research to better understand the effects and effectiveness of pharmaceuticals on maternal and child health. This initiative will ensure that NICHD is able to access quickly and efficiently experts with the ability to support studies relating to pediatric drug and device development.

Requirements

  • Requisite personnel and dedicated staff with experience in managing, designing, conducting, maintaining, and coordinating clinical trial activities in the areas of PK/ PD, safety and efficacy studies for pediatric patients both in the US and abroad
  • Evidence of experience in managing special complexities associated with the design and conduct of multiple and concurrent pediatric clinical trials including patient recruitment and retention, and ethical issues including those related to parental permission and patient assent. In some instances, the pediatric trials may be conducted with exemption from informed consent. Respondents should state their understanding and experience with the informed consent exemption process
  • Evidence of knowledge and experience in producing new pediatric-friendly formulations according to Good Manufacturing Practice (GMP) standards
  •  Experience conducting clinical trials in accordance with Good Clinical Practice (GCP) standards and in conformance to FDA Guidance on performing drug trials in pediatric populations, which includes the maintenance of a communications system in compliance with FDA requirements for the submission of Adverse Event Reports
  • An understanding of the resources and expertise needed for pre-clinical and pediatric clinical trial simulation for PK/PD, safety and efficacy trials
  • Evidence of personnel and services capable of performing statistical analyses of pediatric clinical trials
  • Ability to manage a pediatric clinical trial that will include multiple principal investigators
  • An understanding of adherence to Federal regulations pertaining to human research, and requirements for security and confidentiality of research records
  • Ability to solicit, negotiate, award, administer, and monitor multiple, ongoing subcontracts
  • Experience providing technical support for research activities that may include: planning and conducting meetings with protocol committees; creating protocol development plans and operating protocol development teams; drafting and editing protocols; and developing site-specific, protocol-specific budgets for each protocol
  • Ability to acquire or develop pediatric-friendly formulations of drugs with FDA approval as needed at specific clinical sites. Demonstrate the need to assure that pediatric-friendly formulations are manufactured in accordance with GMP
  • Ability to conduct bioavailability and bioequivalence studies, as needed
  • Ability to generate a plan for acquiring, distributing, dispensing, handling, and administrating study drugs
  • Ability to generate, maintain and present data necessary to the DCC in order to meet all regulatory and reporting requirements of the FDA for labeling of pediatric indications; including maintenance of necessary datasets for submission to FDA and Investigational New Drug (IND) applications

How can GDIC Help?

As a consulting firm that specializes in helping companies prepare winning proposals for government contracts, GDIC can provide a wide range of services to help offerors prepare their C2E proposal, including capture management, proposal writing, proposal management, and proposal review. GDIC can also provide training and support to help offerors understand the technical and administrative requirements outlined in the solicitation, and can provide guidance on how to structure the proposal to maximize its chances of success.

Our business development and proposal professionals have several decades of experience and expertise in construction proposals and contracts for government. By working with GDIC, offerors can increase their chances of winning the C2E contract and can position themselves for long-term success in the federal marketplace.